December 7th, Saturday (5p-7p): Quarterly Business & Educational Meeting sponsored by Teva Pharmaceuticals "Etiology, Diagnosis, and Assessment of Tardive Dyskinesia" at Mediterrano in Ann Arbor
2900 S State St
2900 South State Street
Ann Arbor, MI 48104
Saturday, December 7, 2024 at 5:00pm ET - 7:00pm ET
Add this event to your calendar
Info
Topic
Etiology, Diagnosis, and Assessment of Tardive Dyskinesia
Additional Information
The Etiology, Diagnosis, and Assessment of Tardive Dyskinesia
LIVE EDUCATIONAL PRESENTATION
December 7, 2024
5:00 - 6:00 PM EST
Mediterrano
2900 South State Street
Ann Arbor, MI 48104
DELIVERED BY:
Courtney Leinen, PMHNP-BC, Clinical Science Liaison, Teva Pharmaceuticals
The primary educational topics include:
- Education on the definition, pathophysiology, diagnostic criteria, clinical presentation, risk factors, burden of disease, and incidence/prevalence rate of TD
- Information for how changes in movements caused by TD are captured on the AIMS scale
- A visual illustration of patients with TD undergoing an AIMS assessment by a movement disorder specialist, for HCPs to visualize different severities of TD and the AIMS scores in different parts of the body affected by TD
- A visual illustration of patients with TD performing activities of daily living
Teva Pharmaceuticals strictly adheres to PhRMA guidelines, and we will therefore be unable to accept guests at this program. Space is limited. We urge you to register as quickly as possible to secure your place at the program.
This is an industry program from Teva Pharmaceuticals and is not a CME program.
Speakers
Clinical Science Liaison - Great Lakes
Teva Pharmaceuticals